Overall, this was the first research to construct and validate a prognostic 8-FAMGs signature depending upon the expression of ACBD4, ACOX1, CD36, CPT2, ELOVL3, ELOVL6, ENO2, and SUCLG2 for CRC individuals under strict standards. This evidence concerns the gene CD36 and colorectal carcinoma.